{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:28:24Z","timestamp":1793917704634,"version":"4.8.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["441891347"],"award-info":[{"award-number":["441891347"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-1479"],"award-info":[{"award-number":["SFB-1479"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TTR221"],"award-info":[{"award-number":["TTR221"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jtct.2022.05.038","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T21:38:36Z","timestamp":1654033116000},"page":"426-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8757","authenticated-orcid":false,"given":"Geoffrey D.E.","family":"Cuvelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Schoettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-1997","authenticated-orcid":false,"given":"Nataliya P.","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6338-9218","authenticated-orcid":false,"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg H.W.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-4059","authenticated-orcid":false,"given":"Bianca D.","family":"Santomasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-3393","authenticated-orcid":false,"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-8829","authenticated-orcid":false,"given":"Klemens","family":"Angstwurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli P.A.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Taylor","family":"Kimberly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4466-6528","authenticated-orcid":false,"given":"Ervina","family":"Bilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Banas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9974-6683","authenticated-orcid":false,"given":"Maike","family":"Buettner-Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-1170","authenticated-orcid":false,"given":"Namita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard T.","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0001-6438","authenticated-orcid":false,"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-4314","authenticated-orcid":false,"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4551-6687","authenticated-orcid":false,"given":"Stefanie","family":"Sarantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7015-3190","authenticated-orcid":false,"given":"Daniel","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.05.038_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0002","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0003","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.038_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 highly morbid forms report","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.038_bib0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0006","doi-asserted-by":"crossref","first-page":"e27569","DOI":"10.1002\/pbc.27569","article-title":"Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: a critical review of the literature","volume":"66","author":"Neunert","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.05.038_bib0007","doi-asserted-by":"crossref","first-page":"e28008","DOI":"10.1002\/pbc.28008","article-title":"Hashimoto encephalopathy as manifestation of central nervous system chronic graft-versus-host disease after hematopoietic stem cell transplantation","volume":"66","author":"Vicent","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.05.038_bib0008","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fimmu.2020.02017","article-title":"Autoimmunity following allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Buxbaum","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bmt.1701575","article-title":"Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease","volume":"23","author":"Tse","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0010","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S2352-3026(20)30404-X","article-title":"Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions","volume":"8","author":"Baur","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0011","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1172\/JCI133102","article-title":"Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity","volume":"130","author":"Dertschnig","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.05.038_bib0012","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2004-12-4980","article-title":"Emergent autoimmunity in graft-versus-host disease","volume":"105","author":"Tivol","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0013","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1182\/blood-2012-01-401596","article-title":"Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease","volume":"119","author":"Rangarajan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-016-0678-4","article-title":"Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system","volume":"13","author":"Sinmaz","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jtct.2022.05.038_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.06.012","article-title":"Bystander activation and autoimmunity","volume":"103","author":"Pacheco","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jtct.2022.05.038_bib0016","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/annrheumdis-2018-214125","article-title":"Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification","volume":"78","author":"Zhao","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtct.2022.05.038_bib0017","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-06-438911","article-title":"B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways","volume":"120","author":"Allen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0018","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0019","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1182\/blood-2017-11-784017","article-title":"B-cell targeting in chronic graft-versus-host disease","volume":"131","author":"Zeiser","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0020","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1182\/blood.2020008040","article-title":"BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation","volume":"137","author":"Jia","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0021","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.4049\/jimmunol.154.8.3713","article-title":"Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression","volume":"154","author":"Fischer","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0022","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.immuni.2015.05.013","article-title":"Thymic B cells are licensed to present self-antigens for central T cell tolerance induction","volume":"42","author":"Yamano","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2022.05.038_bib0023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fimmu.2015.00376","article-title":"Thymic B cells and central T cell tolerance","volume":"6","author":"Yamano","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0024","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1182\/blood.2019004710","article-title":"A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation","volume":"135","author":"Davids","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2018.08.028","article-title":"Significant risk of graft-versus-host disease with exposure to checkpoint inhibitors before and after allogeneic transplantation","volume":"25","author":"Ijaz","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000471768","article-title":"Potential role of the PD-1\/PD-L1 axis in the immune regulation of chronic GVHD","volume":"40","author":"Klobuch","year":"2017","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.jtct.2022.05.038_bib0027","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.23885","article-title":"Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria","volume":"90","author":"Kuzmina","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0028","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12026-014-8514-3","article-title":"Clinical impact of H-Y alloimmunity","volume":"58","author":"Popli","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jtct.2022.05.038_bib0029","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1182\/blood-2014-11-613323","article-title":"Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans","volume":"125","author":"Nakasone","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0030","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.3324\/haematol.2018.199646","article-title":"A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation","volume":"104","author":"Paul","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.05.038_bib0031","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.exphem.2006.01.011","article-title":"Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma","volume":"34","author":"Kroger","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0032","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007890-198711000-00010","article-title":"Lymphoid chimerism after allogeneic bone marrow transplantation. Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulins","volume":"44","author":"Korver","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.05.038_bib0033","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2141.2005.05364.x","article-title":"Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation","volume":"128","author":"Griffith","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0034","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bbmt.2017.12.782","article-title":"Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients","volume":"24","author":"Kruizinga","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2022.05.038_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tmrv.2018.02.005","volume":"32","author":"Gonzalez-Vicent","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtct.2022.05.038_bib0036","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbmt.2014.09.009","article-title":"Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital","volume":"21","author":"Wang","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0037","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41409-019-0680-4","volume":"55","author":"Miller","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0038","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbmt.2019.07.022","article-title":"Predictors for autoimmune cytopenias after allogeneic hematopoietic cell transplantation in children","volume":"26","author":"Szanto","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0039","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/JBM.S190327","article-title":"Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives","volume":"10","author":"Barcellini","year":"2019","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.hemonc.2020.07.009","article-title":"Autoimmune hematologic complications of umbilical cord blood transplantation","volume":"14","author":"Ibrahim","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.038_bib0041","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.bbmt.2016.04.005","article-title":"Immune-mediated complications after hematopoietic stem cell transplantation","volume":"22","author":"Li","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0042","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/bloodadvances.2021006279","article-title":"Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics","volume":"6","author":"Migdady","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.05.038_bib0043","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jth.14419","article-title":"The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test","volume":"17","author":"Vrbensky","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtct.2022.05.038_bib0044","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/vox.12227","article-title":"Detection of granulocyte-reactive antibodies: a comparison of different methods","volume":"108","author":"Heinzl","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2022.05.038_bib0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbmt.2013.12.568","article-title":"Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Shono","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0046","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/cells10082051","article-title":"Hematopoietic dysfunction during graft-versus-host disease: a self-destructive process?","volume":"10","author":"Muskens","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jtct.2022.05.038_bib0047","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2009-11-253559","article-title":"Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation","volume":"115","author":"Shono","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0048","doi-asserted-by":"crossref","first-page":"e28591","DOI":"10.1002\/pbc.28591","article-title":"Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects","volume":"67","author":"Koo","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.05.038_bib0049","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fped.2019.00171","article-title":"Autoimmune cytopenias in pediatric hematopoietic cell transplant patients","volume":"7","author":"Neely","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jtct.2022.05.038_bib0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbmt.2013.11.014","article-title":"Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience","volume":"20","author":"Faraci","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.01.015","article-title":"Characterizing immune-mediated cytopenias after allogeneic hematopoietic cell transplantation for pediatric nonmalignant disorders","volume":"27","author":"Galvin","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.038_bib0052","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2020.04.053","article-title":"Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency","volume":"146","author":"Lum","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0053","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/bmt.2016.228","article-title":"Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab","volume":"51","author":"Bhatt","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0054","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5045\/br.2017.52.2.119","article-title":"Treatment and response of autoimmune cytopenia occurring after allogeneic hematopoietic cell transplantation in children","volume":"52","author":"Hwang-Bo","year":"2017","journal-title":"Blood Res"},{"key":"10.1016\/j.jtct.2022.05.038_bib0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bmt.1704705","article-title":"Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation","volume":"35","author":"Raj","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0056","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720961910","article-title":"Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation","volume":"11","author":"Aydin","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0057","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.bbmt.2019.05.023","article-title":"Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of the Spanish Group of Hematopoietic Stem Cell Transplant","volume":"25","author":"Bento","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0058","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/bmt.2014.107","article-title":"Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience","volume":"49","author":"Sanz","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0059","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tmrv.2015.09.001","article-title":"Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of post-transplant autoimmune hemolytic anemia","volume":"30","author":"Park","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtct.2022.05.038_bib0060","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/trf.14907","article-title":"Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept","volume":"58","author":"Hess","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2022.05.038_bib0061","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/pbc.21187","article-title":"Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H","volume":"50","author":"Chao","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.05.038_bib0062","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.03039.x","article-title":"The effect of treatment with Campath-1H in patients with autoimmune cytopenias","volume":"114","author":"Willis","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0063","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1182\/bloodadvances.2018020883","article-title":"Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation","volume":"2","author":"Schuetz","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.05.038_bib0064","doi-asserted-by":"crossref","first-page":"e28010","DOI":"10.1002\/pbc.28010","article-title":"Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia","volume":"67","author":"Even-Or","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.05.038_bib0065","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/bjh.16171","article-title":"Post-allogeneic transplant Evans syndrome successfully treated with daratumumab","volume":"187","author":"Blennerhassett","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0066","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/bloodadvances.2019001215","article-title":"Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review","volume":"4","author":"Migdady","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.05.038_bib0067","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000441507","article-title":"ABO-mismatched allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Worel","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.jtct.2022.05.038_bib0068","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bmt.1705641","article-title":"Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients","volume":"39","author":"Sanz","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0069","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood-2014-08-597245","article-title":"Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD","volume":"125","author":"Dertschnig","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2008.07.006","article-title":"Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation","volume":"14","author":"Page","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0071","first-page":"1093","article-title":"Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation","volume":"17","author":"Drobyski","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0072","doi-asserted-by":"crossref","first-page":"26505","DOI":"10.18632\/oncotarget.15710","article-title":"Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtct.2022.05.038_bib0073","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.bbagen.2016.02.015","article-title":"Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation","volume":"1860","author":"Prenc","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jtct.2022.05.038_bib0074","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1160\/TH13-04-0294","article-title":"Glycosylation of autoantibodies: insights into the mechanisms of immune thrombocytopenia","volume":"110","author":"Bakchoul","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtct.2022.05.038_bib0075","doi-asserted-by":"crossref","first-page":"e44922","DOI":"10.1371\/journal.pone.0044922","article-title":"Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease","volume":"7","author":"Kraus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.05.038_bib0076","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.38293","article-title":"Assessment of joint and fascia manifestations in chronic graft-versus-host disease","volume":"66","author":"Inamoto","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0077","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.38697","article-title":"Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et\u00a0al","volume":"66","author":"Kuzmina","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0078","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0079","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0080","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/brain\/awq245","article-title":"Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease","volume":"133","author":"Grauer","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jtct.2022.05.038_bib0081","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2008.297","article-title":"Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT","volume":"43","author":"Oda","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0082","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2169\/internalmedicine.39.482","article-title":"Myositis as a manifestation of chronic graft-versus-host disease","volume":"39","author":"Takahashi","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0083","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-021-00996-x","article-title":"Clinical characteristics of myositis associated with graft-versus-host disease","volume":"23","author":"Limaye","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jtct.2022.05.038_bib0084","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/mus.27214","article-title":"Immune-mediated neuromuscular complications of graft-versus-host disease","volume":"63","author":"Saw","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtct.2022.05.038_bib0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnen\/nlz111","article-title":"Chronic graft versus host myopathies: noninflammatory, multi-tissue pathology with glycosylation disorders","volume":"79","author":"Pestronk","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0086","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bmt.2011.164","article-title":"Immunohistochemistry of affected tissue may guide cGVHD treatment decisions","volume":"47","author":"Williams","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0087","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2169\/internalmedicine.3322-19","article-title":"Myocarditis with advanced atrioventricular block after allogeneic stem cell transplantation: a case report and literature review","volume":"59","author":"Sumi","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0088","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbmt.2005.07.002","article-title":"Cardiac manifestations of graft-versus-host disease","volume":"11","author":"Rackley","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0089","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thorax.56.1.82","article-title":"Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness","volume":"56","author":"Stephenson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.jtct.2022.05.038_bib0090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.bmt.1702688","article-title":"Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant","volume":"26","author":"Leano","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0091","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","article-title":"Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease","volume":"145","author":"Clark","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0092","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0093","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3899\/jrheum.161433","article-title":"The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: updated recommendations by the OMERACT MRI in Arthritis Working Group","volume":"44","author":"Ostergaard","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0094","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","article-title":"Phenotypic heterogeneity of the endothelium: II. Representative vascular beds","volume":"100","author":"Aird","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jtct.2022.05.038_bib0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","article-title":"Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms","volume":"100","author":"Aird","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jtct.2022.05.038_bib0096","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3324\/haematol.2020.253716","article-title":"Endothelial damage and dysfunction in acute graft-versus-host disease","volume":"106","author":"Cordes","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.05.038_bib0097","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/bmt.2017.119","article-title":"Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD","volume":"52","author":"Zeisbrich","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0098","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbmt.2010.02.016","article-title":"Prediction of veno-occlusive disease using biomarkers of endothelial injury","volume":"16","author":"Cutler","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0099","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3324\/haematol.2019.238790","article-title":"Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel","volume":"106","author":"Jiang","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.05.038_bib0100","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood-2006-10-054080","article-title":"Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation","volume":"110","author":"Tichelli","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0101","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3324\/haematol.12949","article-title":"Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation","volume":"93","author":"Tichelli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.05.038_bib0102","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.05.038_bib0103","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-2133.2010.09667.x","article-title":"Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy","volume":"162","author":"Akay","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0104","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/lsm.22788","article-title":"Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions","volume":"50","author":"Deegan","year":"2018","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2013-03-488148","article-title":"Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation","volume":"122","author":"Tardieu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.wneu.2018.11.256","article-title":"Extracranial-intracranial bypass for cerebral vasculitis after graft-versus-host disease: case report and review of the literature","volume":"123","author":"Nakayama","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jtct.2022.05.038_bib0107","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bmt.1704625","article-title":"Coronary vessel involvement by chronic graft-versus-host disease presenting as sudden cardiac death","volume":"34","author":"Prevost","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0108","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00415-009-5272-6","article-title":"Large vessel vasculitis: manifestation of graft-versus-host disease?","volume":"256","author":"Sostak","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2169\/internalmedicine.56.7329","article-title":"Chronic graft-versus-host disease presenting with multiple punctate intracranial lesions on contrast-enhanced magnetic resonance imaging","volume":"56","author":"Terada","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1827.2011.02704.x","article-title":"Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"key":"10.1016\/j.jtct.2022.05.038_bib0111","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0112","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbmt.2016.10.011","article-title":"Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"23","author":"Clavert","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0113","first-page":"2243","article-title":"Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St","volume":"1","author":"Eissa","year":"2017","journal-title":"Jude Lifetime Cohort Study"},{"key":"10.1016\/j.jtct.2022.05.038_bib0114","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exphem.2013.07.003","article-title":"Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events","volume":"42","author":"Pophali","year":"2014","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bbmt.2016.05.007","article-title":"Metabolic syndrome and cardiovascular disease after hematopoietic cell transplantation: screening and preventive practice recommendations from the CIBMTR and EBMT","volume":"22","author":"DeFilipp","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0116","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-021-00488-2","article-title":"High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group","volume":"11","author":"El Jurdi","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2022.05.038_bib0117","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Zoller","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.05.038_bib0118","doi-asserted-by":"crossref","first-page":"e13474","DOI":"10.1111\/petr.13474","article-title":"Coronary artery involvement in chronic graft-versus-host disease presenting as sudden cardiac arrest","volume":"23","author":"Kim","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676756","article-title":"Von Willebrand factor, factor VIII, and other acute phase reactants as biomarkers of inflammation and endothelial dysfunction in chronic graft-versus-host disease","volume":"12","author":"Lelas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0120","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1703026","article-title":"Serum levels of soluble adhesion molecules in stem cell transplantation-related complications","volume":"27","author":"Matsuda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0121","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1182\/blood-2015-09-668251","article-title":"Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells","volume":"127","author":"Kariminia","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0122","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.3390\/ijms21249768","article-title":"Assessment of endothelial injury and pro-coagulant activity using circulating microvesicles in survivors of allogeneic hematopoietic cell transplantation","volume":"21","author":"Gavriilaki","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtct.2022.05.038_bib0123","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1200\/JCO.2015.65.9615","article-title":"Biomarker panel for chronic graft-versus-host disease","volume":"34","author":"Yu","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0124","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2012-02-413260","article-title":"Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD","volume":"120","author":"Croudace","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0125","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood-2013-08-520072","article-title":"Plasma CXCL9 elevations correlate with chronic GVHD diagnosis","volume":"123","author":"Kitko","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41408-021-00434-2","article-title":"Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD","volume":"11","author":"Dai","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2022.05.038_bib0127","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood-2018-03-841155","article-title":"Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice","volume":"132","author":"Radojcic","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0128","first-page":"22","article-title":"Ocular graft-versus-host disease in a chemotherapy-based minor-mismatch mouse model features corneal (lymph-) angiogenesis","author":"Gehlsen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtct.2022.05.038_bib0129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood.2019000032","article-title":"Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease","volume":"135","author":"Thangavelu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0130","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2016-08-736314","article-title":"Initiation of acute graft-versus-host disease by angiogenesis","volume":"129","author":"Riesner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0131","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/djq172","article-title":"Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth","volume":"102","author":"Penack","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2022.05.038_bib0132","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1182\/blood-2010-10-312934","article-title":"The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Penack","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0133","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/pon.3159","article-title":"Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study","volume":"22","author":"Scherwath","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.jtct.2022.05.038_bib0134","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.3324\/haematol.2019.225326","article-title":"Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation","volume":"105","author":"Boberg","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.05.038_bib0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2017.74.2270","article-title":"Cognitive functioning after hematopoietic cell transplantation for hematologic malignancy: results from a prospective longitudinal study","volume":"36","author":"Sharafeldin","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0136","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.2010.33.9119","article-title":"Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years","volume":"29","author":"Syrjala","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0137","article-title":"Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behaviour during chronic GVHD in mice","author":"Adams","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0138","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI130272","article-title":"Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia","volume":"130","author":"Mathew","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.05.038_bib0139","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2012-09-456590","article-title":"The central nervous system is a target of acute graft versus host disease in mice","volume":"121","author":"Hartrampf","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0140","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2014-01-547612","article-title":"CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis","volume":"123","author":"Kaliyaperumal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0141","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00005072-199309000-00004","article-title":"Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study","volume":"52","author":"Unger","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0142","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/bmt.2014.29","article-title":"Acute disseminated encephalomyelitis following allo-SCT: central nervous system manifestation of GVHD","volume":"49","author":"Harvey","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0143","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000439490","article-title":"Retinal involvement in a patient with cerebral manifestation of chronic graft-versus-host-disease","volume":"38","author":"Blecha","year":"2015","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.jtct.2022.05.038_bib0144","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2005.05864.x","article-title":"Central nervous system graft-versus-host disease post allogeneic stem cell transplant","volume":"132","author":"Shortt","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0145","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.STR.30.8.1651","article-title":"Angiitis of the central nervous system after allogeneic bone marrow transplantation?","volume":"30","author":"Padovan","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jtct.2022.05.038_bib0146","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1212\/01.WNL.0000038948.09158.A7","article-title":"CNS angiitis in graft vs host disease","volume":"59","author":"Ma","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2022.05.038_bib0147","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.bmt.1705709","article-title":"Central nervous system graft-versus-host disease presenting with granulomatous encephalitis","volume":"40","author":"Kew","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0148","doi-asserted-by":"crossref","first-page":"e8303","DOI":"10.1097\/MD.0000000000008303","article-title":"Central nervous system involvement of human graft versus host disease: report of 7 cases and a review of literature","volume":"96","author":"Ruggiu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtct.2022.05.038_bib0149","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fimmu.2020.00668","article-title":"A case of multiple sclerosis-like relapsing remitting encephalomyelitis following allogeneic hematopoietic stem cell transplantation and a review of the published literature","volume":"11","author":"Das","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2018.08.003","article-title":"Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"323","author":"Pirotte","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0151","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021012431","article-title":"Non-classical manifestations of acute GVHD","author":"Zeiser","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.038_bib0152","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","article-title":"Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology","volume":"78","author":"Cella","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2022.05.038_bib0153","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbmt.2019.09.037","article-title":"Patient-reported neuropsychiatric outcomes of long-term survivors after chimeric antigen receptor T cell therapy","volume":"26","author":"Ruark","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0154","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1355617703930074","article-title":"The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals","volume":"9","author":"Collie","year":"2003","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.jtct.2022.05.038_bib0155","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtct.2022.05.038_bib0156","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/2159-8290.CD-17-1319","article-title":"Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia","volume":"8","author":"Santomasso","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtct.2022.05.038_bib0157","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8110523","article-title":"Blood neurofilament light chain: the neurologist's troponin?","volume":"8","author":"Thebault","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtct.2022.05.038_bib0158","article-title":"Serum neurofilament light in MS: the first true blood-based biomarker?","author":"Thebault","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.jtct.2022.05.038_bib0159","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jtct.2022.05.038_bib0160","doi-asserted-by":"crossref","first-page":"10381","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtct.2022.05.038_bib0161","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.0000000000010346","article-title":"Serum neurofilament light as a biomarker in progressive multiple sclerosis","volume":"95","author":"Kapoor","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2022.05.038_bib0162","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","article-title":"Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study","volume":"30","author":"McDonald","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jtct.2022.05.038_bib0163","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncr.22368","article-title":"Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy","volume":"109","author":"Inagaki","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.05.038_bib0164","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2013-306657","article-title":"Immune-mediated neuropathies following stem cell transplantation","volume":"85","author":"Karam","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtct.2022.05.038_bib0166","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bbmt.2019.04.021","article-title":"Incidence, risk factors, and outcome of immune-mediated neuropathies (imns) following haploidentical hematopoietic stem cell transplantation","volume":"25","author":"Ren","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0167","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/WNL.46.4.1004","article-title":"Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study","volume":"46","author":"Graus","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2022.05.038_bib0168","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0030-1255218","article-title":"Neurologic complications of hematopoietic cell transplantation","volume":"30","author":"Saiz","year":"2010","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0169","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.50.5.1441","article-title":"Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study","volume":"50","author":"Antonini","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jtct.2022.05.038_bib0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1704538","article-title":"Neurological complications following alemtuzumab-based reduced-intensity allogeneic transplantation","volume":"34","author":"Avivi","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0171","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.bbmt.2009.07.013","article-title":"Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"15","author":"Barba","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0172","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bmt.2016.158","article-title":"High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD","volume":"51","author":"Bilic","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0173","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(85)91742-8","article-title":"Bone-marrow grafting induces acetylcholine receptor antibody formation","volume":"1","author":"Smith","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2022.05.038_bib0174","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hemonc.2017.04.001","article-title":"Myasthenia gravis after allogeneic bone marrow transplantation: a case report and literature review","volume":"12","author":"Tsutsumi","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.038_bib0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0176","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2215\/CJN.08580719","article-title":"Acute kidney injury and CKD associated with hematopoietic stem cell transplantation","volume":"15","author":"Renaghan","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0177","first-page":"179","article-title":"Graft-versus-host disease. Morphologic variation and differential diagnosis in 8 cases of HL-A matched bone marrow transplantation","volume":"63","author":"Kruger","year":"1971","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0178","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ejh.12149","article-title":"Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant","volume":"91","author":"Fraile","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0179","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.ajkd.2005.05.026","article-title":"Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis","volume":"46","author":"Romagnani","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jtct.2022.05.038_bib0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1752-1947-1-121","article-title":"Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review","volume":"1","author":"Silva","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jtct.2022.05.038_bib0181","first-page":"357","article-title":"Renal involvement in chronic graft-versus-host disease: a report of two cases","volume":"3","author":"Gomez-Garcia","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0182","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000046273","article-title":"Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature","volume":"21","author":"Lin","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0183","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1532\/IJH97.05074","article-title":"Nephrotic syndrome with extensive mesangiolysis as a clinical manifestation of chronic graft-versus-host disease (GVHD)","volume":"82","author":"Kawakami","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0184","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(74)80655-4","article-title":"Adenosine deaminase deficiency: the first inborn error of metabolism noted in immunodeficiency disease","volume":"84","year":"1974","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2022.05.038_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.krcp.2013.07.004","article-title":"De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a single-center experience","volume":"32","author":"Cho","year":"2013","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jtct.2022.05.038_bib0186","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bmt.1704896","article-title":"Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation","volume":"35","author":"Homma","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0187","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2017.11.008","article-title":"Kidney pathology after hematologic cell transplantation-a single-center observation study of indication biopsies and autopsies","volume":"24","author":"Girsberger","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0188","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2215\/CJN.01840214","article-title":"Urinary elafin and kidney injury in hematopoietic cell transplant recipients","volume":"10","author":"Hingorani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0189","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-3083.1988.tb02412.x","article-title":"Monoclonal autoantibodies specific for kidney proximal tubular brush border from mice with experimentally induced chronic graft-versus-host disease","volume":"28","author":"Rolink","year":"1988","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2249.1990.tb05137.x","article-title":"Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease","volume":"79","author":"Bruijn","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0191","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<307::AID-PATH5>3.0.CO;2-W","article-title":"Differential expression of collagen IV isoforms in experimental glomerulosclerosis","volume":"184","author":"Bergijk","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0192","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH707>3.0.CO;2-L","article-title":"Differential expression of laminin chains and anti-laminin autoantibodies in experimental lupus nephritis","volume":"192","author":"Peutz-Kootstra","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0193","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/imj.13098","article-title":"Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantation","volume":"46","author":"Wong","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.jtct.2022.05.038_bib0194","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00277-020-04193-1","article-title":"Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis","volume":"99","author":"Fante","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0195","doi-asserted-by":"crossref","first-page":"e14263","DOI":"10.1111\/petr.14263","article-title":"A case of treatment-resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab","author":"Benoit","year":"2022","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0196","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.lpm.2010.11.004","article-title":"Pleural and pulmonary involvement in systemic lupus erythematosus","volume":"40","author":"Torre","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.jtct.2022.05.038_bib0197","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/bmt.2015.105","article-title":"Chronic GvHD-associated serositis and pericarditis","volume":"50","author":"Leonard","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0198","first-page":"207","article-title":"Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease","volume":"17","author":"Seber","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0199","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/bmt.2010.297","article-title":"Large pericardial effusion as a complication in adults undergoing SCT","volume":"46","author":"Norkin","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0200","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00277-012-1541-z","article-title":"Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0201","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1161\/CIRCHEARTFAILURE.113.000462","article-title":"Pericardial constriction attributable to graft-versus-host disease: importance of early immunosuppression","volume":"6","author":"Morley-Smith","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jtct.2022.05.038_bib0202","doi-asserted-by":"crossref","first-page":"e13748","DOI":"10.1111\/petr.13748","article-title":"Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes","volume":"24","author":"Tinianow","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bjh.13357","article-title":"Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation","volume":"169","author":"Liu","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0204","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1002\/ajh.24435","article-title":"Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Modi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.05.038_bib0205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2022.05.038_bib0206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1705023","article-title":"Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients","volume":"36","author":"Rhodes","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.038_bib0207","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722013343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722013343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:05:56Z","timestamp":1763003156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722013343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":207,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2666636722013343"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.05.038","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}